Can euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors be avoided in COVID-19 and other acute infections?

Can euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors be avoided in COVID-19 and other acute infections?

Introduction: We present a case of anion gap euglycemic diabetic ketoacidosis (EuDKA) in a patient with COVID-19 infection. Patients with diabetes mellitus are at increased risk of severe illness, and hyperglycaemia is associated with higher morbidity and mortality in patients infected with COVID-19...

Full description

Bibliographic Details
Main Authors: Georgios Pilianidis, Georgia Papanastasiou, Pinelopi Tikoudi, Andreas Themistocleous, Georgios Farmakis, Konstantinos Dolianitis
Format: Article
Language:English
Published: SMC MEDIA SRL 2024-02-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
covid-19
diabetic ketoacidosis
euglycemic
sglt-2 inhibitors
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/4282

Internet

https://www.ejcrim.com/index.php/EJCRIM/article/view/4282

Similar Items